TransMedics Group Inc vs TTM Technologies Inc. Common Stock — how do they compare? TransMedics Group Inc trades at $80.68 (market cap $2.74B), while TTM Technologies Inc. Common Stock trades at $120.69 (market cap $12.38B). The key difference: TTM Technologies Inc. Common Stock is far larger — about 4.5× TransMedics Group Inc's market cap, and TTM Technologies Inc. Common Stock is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and TTM Technologies Inc. Common Stock for 0 Days on average.
| TMDX | TTMI | |
|---|---|---|
Market Cap | $2.74B | $12.38B |
Volume | 949,331 | 2,258,598 |
Sector | Health | Technology |
52-Week High | $150.42 | $221.47 |
52-Week Low | $61.99 | $53.58 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $3.13B | $12.97B |
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.
The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →